deltatrials
Unknown PHASE3 INTERVENTIONAL 4-arm NCT01479504

A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

A Multicenter Trial Evaluating the Efficacy and Safety of Nedaplatin Plus Docetaxel in Neoadjuvant Chemotherapy Followed by Nedaplatin in Concurrent Chemoradiation for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Sponsor: 303rd Hospital of the People's Liberation Army

Conditions Nasopharyngeal Carcinoma
Interventions cisplatin and docetaxel nedaplatin and docetaxel
Updated 12 times since 2017 Last updated: Nov 24, 2011 Started: Nov 30, 2011 Primary completion: Nov 30, 2012 Completion: Dec 31, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Nasopharyngeal Carcinoma and is currently ongoing. 303rd Hospital of the People's Liberation Army leads this study, which shows 12 recorded versions since 2011 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Feb 2018 · 12 months · monthly snapshotRecruiting~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshotUnknown Status~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshotUnknown Status~Aug 2018 – ~Apr 2020 · 20 months · monthly snapshotUnknown Status~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshotUnknown Status~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotUnknown Status~Oct 2021 – ~Jul 2024 · 33 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshotUnknown~Jun 2025 – ~Jul 2025 · 30 days · monthly snapshotUnknown~Jul 2025 – present · 14 months · monthly snapshotUnknown

Change History

12 versions recorded

  1. Jul 2025 — Present [monthly]

    Unknown PHASE3

  2. Jun 2025 — Jul 2025 [monthly]

    Unknown PHASE3

  3. Sep 2024 — Jun 2025 [monthly]

    Unknown PHASE3

  4. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown Status → Unknown

  5. Oct 2021 — Jul 2024 [monthly]

    Unknown Status PHASE3

▶ Show 7 earlier versions

  1. Jan 2021 — Oct 2021 [monthly]

    Unknown Status PHASE3

  2. Apr 2020 — Jan 2021 [monthly]

    Unknown Status PHASE3

  3. Aug 2018 — Apr 2020 [monthly]

    Unknown Status PHASE3

  4. Jun 2018 — Aug 2018 [monthly]

    Unknown Status PHASE3

  5. Feb 2018 — Jun 2018 [monthly]

    Unknown Status PHASE3

    Status: Recruiting → Unknown Status

  6. Feb 2017 — Feb 2018 [monthly]

    Recruiting PHASE3

  7. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE3

    First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • 303rd Hospital of the People's Liberation Army
  • First People's Hospital of Yulin
  • Guangxi Medical University
  • Guangxi Naxishan Hospital
  • Guangxi Traditional Chinese Medical University
  • Guigang People's Hospital
  • Guilin Medical College
  • LiuZhou People's Hospital
  • Liuzhou Cancer Hospital
  • Liuzhou Hospital of Traditional Chinese Medicine
  • Liuzhou Railway hospital
  • Liuzhou Workers' Hospital
  • Nanning Second People's Hospital
  • People's Hospital of Guangxi Zhuang Autonomous Region
  • The Red Cross hospital of YuLin
  • Wuzhou Red Cross Hospital
Data source: Guangxi Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations